Jeff Yass’s Sunshine Biopharma SBFM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.2K Buy
+920
New +$24.5K ﹤0.01% 13185
2024
Q3
– Sell
-19
Closed -$32.1K – 12906
2024
Q2
$32.1K Buy
+19
New +$181K ﹤0.01% 11546
2022
Q4
– Hold
0
– -$11K – 13524
2022
Q3
– Hold
0
– – – 12762

Other funds holding SBFM

Jeff Yass's SBFM Position: Q3 2026 in Review

Jeff Yass opened a new position in Sunshine Biopharma (SBFM) in Q3 2026: 920 shares worth $14.2K. The stake represents ﹤0.01% of the portfolio and ranks #13185 among its holdings. This is a return to the name: Jeff Yass previously reported a position in SBFM as recently as Q2 2024.

Jeff Yass first reported a position in SBFM in Q2 2024 and has held it in 2 quarters since. The position peaked at $32.1K in Q2 2024. 10 funds tracked by Wall St. Rank hold SBFM as of Q3 2026.

  • Jeff Yass held 920 shares of Sunshine Biopharma worth $14.2K as of Q3 2026.
  • Sunshine Biopharma was a new Jeff Yass position in Q3 2026.
  • Sunshine Biopharma made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13185 holding.
  • Jeff Yass first reported a position in Sunshine Biopharma in Q2 2024 and has held it in 2 quarters since.
  • Jeff Yass's Sunshine Biopharma position peaked at $32.1K in Q2 2024.
  • 10 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.